Literature DB >> 20810981

Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population.

John Sidney1, Amiyah Steen, Carrie Moore, Sandy Ngo, Jolan Chung, Bjoern Peters, Alessandro Sette.   

Abstract

Knowledge of the binding repertoires and specificities of HLA-DQ molecules is somewhat limited and contradictory, partly because of the scarcity of reports addressing some of the most common molecules and possibly because of the diversity of the techniques used. In this paper, we report the development of high-throughput binding assays for the six most common DQ molecules in the general worldwide population. Using comprehensive panels of single substitution analogs of specific ligands, we derived detailed binding motifs for DQA1*0501/DQB1*0301, DQA1*0401/DQB1*0402, and DQA1*0101/DQB1*0501 and more detailed motifs for DQA1*0501/DQB1*0201, DQA1*0301/DQB1*0302, and DQA1*0102/DQB1*0602, previously characterized on the basis of sets of eluted ligands and/or limited sets of substituted peptides. In contrast to what has previously been observed for DR and DP molecules, DQ motifs were generally less clearly defined in terms of chemical specificity and, strikingly, had little overlap with each other. However, testing a panel of peptides spanning a set of Phleum pratense Ags, and panels of known DQ epitopes, revealed a surprisingly significant and substantial overlap in the repertoire of peptides bound by these DQ molecules. Although the mechanism underlying these apparently contradictory findings is not clear, it likely reflects the peculiar mode of interaction between DQ (and not DR or DP) molecules and their peptide ligands. Because the DQ molecules studied are found in >85% of the general human population, these findings have important implications for epitope identification studies and monitoring of DQ-restricted immune responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810981      PMCID: PMC3307390          DOI: 10.4049/jimmunol.1001006

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  87 in total

1.  Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.

Authors:  A K Moustakas; Y van de Wal; J Routsias; Y M Kooy; P van Veelen; J W Drijfhout; F Koning; G K Papadopoulos
Journal:  Int Immunol       Date:  2000-08       Impact factor: 4.823

2.  On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs.

Authors:  D O'Sullivan; T Arrhenius; J Sidney; M F Del Guercio; M Albertson; M Wall; C Oseroff; S Southwood; S M Colón; F C Gaeta
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

Review 3.  Extreme genetic risk for type 1A diabetes in the post-genome era.

Authors:  Erin E Baschal; George S Eisenbarth
Journal:  J Autoimmun       Date:  2008-05-01       Impact factor: 7.094

4.  Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays.

Authors:  B H Johansen; H A Gjertsen; F Vartdal; S Buus; E Thorsby; K E Lundin; L M Sollid
Journal:  Clin Immunol Immunopathol       Date:  1996-06

5.  A biological role for the major histocompatibility antigens.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Lancet       Date:  1975-06-28       Impact factor: 79.321

6.  Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.

Authors:  K H Lee; K W Wucherpfennig; D C Wiley
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

7.  Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype.

Authors:  D Ou; L A Mitchell; D Décarie; A J Tingle; G T Nepom
Journal:  Hum Immunol       Date:  1998-03       Impact factor: 2.850

8.  Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8.

Authors:  R M Chicz; W S Lane; R A Robinson; M Trucco; J L Strominger; J C Gorga
Journal:  Int Immunol       Date:  1994-11       Impact factor: 4.823

9.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

10.  SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens.

Authors:  Vandana Gupta; Tani M Tabiin; Kai Sun; Ananth Chandrasekaran; Azlinda Anwar; Kun Yang; Priya Chikhlikar; Jerome Salmon; Vladimir Brusic; Ernesto T A Marques; Srinivasan N Kellathur; Thomas J August
Journal:  Virology       Date:  2006-01-04       Impact factor: 3.616

View more
  40 in total

1.  Characterizing the binding motifs of 11 common human HLA-DP and HLA-DQ molecules using NNAlign.

Authors:  Massimo Andreatta; Morten Nielsen
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

2.  Distinct evolutionary strategies of human leucocyte antigen loci in pathogen-rich environments.

Authors:  Alicia Sanchez-Mazas; Jean-François Lemaître; Mathias Currat
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

3.  A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity.

Authors:  Mark Yarmarkovich; John M Warrington; Alvin Farrel; John M Maris
Journal:  SSRN       Date:  2020-04-14

4.  Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Authors:  John Sidney; Scott Southwood; Carrie Moore; Carla Oseroff; Clemencia Pinilla; Howard M Grey; Alessandro Sette
Journal:  Curr Protoc Immunol       Date:  2013-02

Review 5.  Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism.

Authors:  Hiroko Miyadera; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2015-08-20       Impact factor: 3.172

6.  T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.

Authors:  Ruth A Ettinger; Pedro Paz; Eddie A James; Devi Gunasekera; Fred Aswad; Arthur R Thompson; Dana C Matthews; Kathleen P Pratt
Journal:  Blood       Date:  2016-07-28       Impact factor: 22.113

7.  Development of a strategy and computational application to select candidate protein analogues with reduced HLA binding and immunogenicity.

Authors:  Sandeep Kumar Dhanda; Alba Grifoni; John Pham; Kerrie Vaughan; John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Immunology       Date:  2017-09-28       Impact factor: 7.397

Review 8.  The identification of potentially pathogenic and therapeutic epitopes from common human allergens.

Authors:  Véronique Schulten; Carla Oseroff; Rafeul Alam; David Broide; Pandurangan Vijayanand; Bjoern Peters; Alessandro Sette
Journal:  Ann Allergy Asthma Immunol       Date:  2012-11-15       Impact factor: 6.347

Review 9.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

10.  Peptide binding predictions for HLA DR, DP and DQ molecules.

Authors:  Peng Wang; John Sidney; Yohan Kim; Alessandro Sette; Ole Lund; Morten Nielsen; Bjoern Peters
Journal:  BMC Bioinformatics       Date:  2010-11-22       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.